CA-ENEVATE-CORPORATION
Enevate Corporation , a lithium-ion (Li-ion) battery technology company, announces HD-Energy® Technology for Electric Vehicles (EVs) which features extreme fast charging in only 5 minutes with high energy density and long driving range that adds up to 240 miles (390 km)—or up to 50 miles (80 km) range with a 60-second charge. This fast charge and very short charging times are better than any other Li-ion technology available today, while meeting automotive requirements for energy density, range, and cost. Enevate licenses its silicon-dominant HD-Energy® Technology to battery and EV automotive manufacturers and suppliers worldwide.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171102005395/en/
This new extreme fast charge technology breaks down the barriers to electric vehicle adoption. EVs have been challenged primarily due to their limited range and drivers’ “range anxiety,” long charge times, and high cost. Now, Enevate’s groundbreaking silicon Li-ion battery technology in EV cells (NCM-based) can be charged in 5 minutes at up to a tested 10C charging rate to 75% capacity with uncompromised range and energy densities of over 750 Wh/L, where conventional graphite cells suffer significant degradation with extreme fast charging.
This 5-minute charging allows flow-through charging stations where EV drivers wait just a few minutes to “fill up” just as they would with regular gas stations. In addition, with such short charging times, smaller batteries can be used in some EVs making them much more affordable.
“The benefits of Enevate’s silicon-dominant HD-Energy Technology enable next-generation features that take EVs to the next level,” says Founder & Chief Technology Officer Dr. Benjamin Park . “Extreme fast charges for very short and convenient charging times, higher energy density leading to longer driving ranges, and cold temperature operation with inherent safety advantages make this technology ideal for electric vehicles.”
Enevate’s HD-Energy battery technology can safely charge and discharge down to -40°C and capture more energy during regenerative braking, extending their range in cold climates. A key safety benefit is that Enevate’s HD-Energy Technology is inherently resistant to lithium-plating during fast charge and also during charging in low temperatures, which is a major challenge for conventional graphite Li-ion cells.
Lithium-ion battery pioneer Dr. John Goodenough at University of Texas in Austin agrees, saying “Enevate’s film-based silicon-dominant anode and cell is a truly novel approach and great practical fit for use in EVs addressing the major barriers to EV adoption.”
About Enevate
Enevate Corporation , with global headquarters in California USA, develops and licenses advanced silicon-dominant Li-ion battery technology that revolutionizes the electric vehicle (EV) market by breaking down barriers to EV adoption. Enevate's pioneering work on silicon-dominant anodes and cells has resulted in its breakthrough HD-Energy® Technology featuring extreme fast charging with uncompromised high energy density, excellent low-temperature operation for cold climates, and safety advantages over conventional graphite Li-ion batteries.
Investors include Mission Ventures, Draper Fisher Jurvetson, Tsing Capital, Infinite Potential Technologies, Presidio Ventures – a Sumitomo Corporation company, and CEC Capital. Enevate, the Enevate logo, HD-Energy, and eBoost are registered trademarks of the Enevate Corporation. To learn more about or to license Enevate’s industry-defining battery technology, visit www.enevate.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20171102005395/en/
Contact:
On behalf of Enevate
Lynn Lewis, 480.775.8880
media@enevate.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Perma-Pipe International Holdings, Inc. Announces New Contract Award in Qatar27.5.2025 21:48:00 CEST | Press release
Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) today announced that it has received its first project award to be executed in Qatar since the announcement of the intent to mobilize there. The project will be for USD $2.4 million and will utilize Perma-Pipe’s fabrication capabilities and the XTRU-THERM® insulation system, a spray-applied polyurethane foam jacketed with a high-density polyethylene casing. Adham Sharkawy, Senior Vice President of Perma-Pipe’s MENA region, remarked, “In response to this important award, we will begin executing the project from a temporary facility in Doha, ensuring timely delivery and uninterrupted service to our client. Simultaneously, we are advancing the construction of our permanent facility in Qatar, which will serve as a long-term base for our regional operations. We are deeply grateful to our customers for their continued trust and confidence in Perma-Pipe’s capabilities.” Saleh Sagr, President, commented, “Expanding in Doha has been an impo
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,
LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release
~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut
The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release
The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom